Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MET-2 in Major Depressive Disorder
NCT04602715Phase 2Unknown
- Sponsor
- NuBiyota
- Start
- Apr 2021
- Primary completion
- Jun 2021
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of MET-2 in major depressive disorder (MDD), anxiety disorder, sponsored by NuBiyota. Status: unknown.
02
Drugs
MET-2
03
Conditions
major depressive disorder (MDD)anxiety disorder
Beyond the preview
Go deeper on NCT04602715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04602715.